双孔鼓膜穿刺鼓室注药法治疗急性分泌性中耳炎的临床研究  

Preliminary study on diplopore puncture of tympanum and intratympanic administration for management of acute secretory otitis media

作　　者：谭祖林[1] 张扬[2] 徐先荣[2] 张继东[1] 金占国[1] 

机构地区：[1]空军总医院耳鼻咽喉科,北京100142 [2]空军总医院全军临床航空医学中心

出　　处：《临床耳鼻咽喉头颈外科杂志》2010年第1期16-18,共3页Journal of Clinical Otorhinolaryngology Head And Neck Surgery

摘　　要：目的:评估双孔鼓膜穿刺鼓室注药法对急性分泌性中耳炎的治疗作用。方法:以141例急性分泌性中耳炎患者为研究对象,随机分为治疗组和对照组,治疗组69例(80耳),采用双孔鼓膜穿刺鼓室注药结合常规药物治疗;对照组72例(84耳),采用单孔鼓膜穿刺抽液结合常规药物治疗。治疗1～3个疗程,分别比较2组患者在各个疗程结束后的疗效。随访观察2组患者在治疗期间及疗程结束后3个月的不良反应与并发症。结果:治疗前患者性别、年龄、患耳侧别、病程、听力学检查情况等可能影响预后的各因素在2组间匹配良好,差异无统计学意义(P>0.05)。治疗1～3个疗程,治疗组的治愈率和总有效率均高于对照组,2组间差异有统计学意义(P<0.05)。在治疗期间及疗程结束后3个月,2组患者均未出现不良反应或并发症。结论:双孔鼓膜穿刺鼓室注药法是治疗急性分泌性中耳炎的一种安全、可靠和有效的方法。Objective：To evaluate the therapeutical effects of diplopore puncture of tympanum and intratympanic administration（DPTIA）on patients with acute secretory otitis media（ASOM）.Method：One hundred and forty-one cases with ASOM were divided into two groups randomly,with 69 cases（80 ears）in group A（experimental group）and 72 cases（84 ears）in group B（control group）.Group A was treated with DPTIA combined with medication,group B was treated with haplopore puncture of tympanum combined with medication.All patients accepted 1 to 3 courses of treament,and were observed during the period of treatment and 3 months after treatment.Result：The factors（including gender,age,side of ailing ear,course of disease,air-bone gap in the pure tone average,and acoustic immitance type in ailing ear）which may impact the prognosis were matched in two groups prior treatment（P0.05）.While there was a significant difference in the cure rate and the total effective rate respectively between two groups after treatment（P0.05）.No adverse reaction or complication was seen.Conclusion：DPTIA is a safe,reliable and effective way to manage patients with ASOM.

关 键 词：中耳炎 急性 分泌性 鼓膜穿刺 鼓室注药 

分 类 号：R764.21[医药卫生—耳鼻咽喉科]